Table 2.

Mutations in Patients With Nonsevere Hemophilia and Inhibitors

LocationMutationFactor VIII Level (%)Reference
DomainExonCodonCodon/Amino AcidVIII:CVIII:Ag
 
A1 198  CTT to CAT 
   Leu to His   
     Pieneman et al19   
A2 12 593 CGC to TGC 13  
   Arg to Cys    
A2 14 701 GGC to AGC  —  Bidichandani et al20  
    Gly to Asp    
A3 14 1689 CGC to CAC 11 100 Schwaab et al21  
   Arg to His    
C1 2150 CGT to CAT 12  —  Santagostino et al22* 
   Arg to His    
C2 24 2209 CGA to CAA 130 Schwaab et al23* 
   Arg to Gln    
C2 25 2229 TGG to TGT  —  Naylor et al24  
    Trp to Cys    
LocationMutationFactor VIII Level (%)Reference
DomainExonCodonCodon/Amino AcidVIII:CVIII:Ag
 
A1 198  CTT to CAT 
   Leu to His   
     Pieneman et al19   
A2 12 593 CGC to TGC 13  
   Arg to Cys    
A2 14 701 GGC to AGC  —  Bidichandani et al20  
    Gly to Asp    
A3 14 1689 CGC to CAC 11 100 Schwaab et al21  
   Arg to His    
C1 2150 CGT to CAT 12  —  Santagostino et al22* 
   Arg to His    
C2 24 2209 CGA to CAA 130 Schwaab et al23* 
   Arg to Gln    
C2 25 2229 TGG to TGT  —  Naylor et al24  
    Trp to Cys    

Factor VIII abbreviations are as in Table 1.

*

Maximal inhibitor titer reported and >100 BU/mL.

or Create an Account

Close Modal
Close Modal